Robert Ticktin - Apr 21, 2025 Form 3 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
General Counsel & COO
Signature
/s/ Robert Ticktin
Stock symbol
PMVP
Transactions as of
Apr 21, 2025
Transactions value $
$0
Form type
3
Date filed
4/23/2025, 06:10 PM
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PMVP Common Stock 106K Apr 21, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PMVP Employee Stock Option (right to buy) Apr 21, 2025 Common Stock 1.45K $4.22 Direct F2
holding PMVP Employee Stock Option (right to buy) Apr 21, 2025 Common Stock 102K $8.53 Direct F2
holding PMVP Employee Stock Option (right to buy) Apr 21, 2025 Common Stock 169K $1.80 Direct F3
holding PMVP Employee Stock Option (right to buy) Apr 21, 2025 Common Stock 196K $1.48 Direct F4
holding PMVP Employee Stock Option (right to buy) Apr 21, 2025 Common Stock 265K $1.32 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 79,150 shares represented by restricted stock units, or RSUs, all of which vest on June 30, 2025.
F2 Shares subject to the option are fully vested and immediately exercisable.
F3 Shares subject to the option vest in 48 equal monthly installments beginning on February 18, 2024.
F4 One-third of the shares subject to the option vest on August 13, 2025 and 1/36th vest monthly thereafter.
F5 Shares subject to the option vest in 48 equal monthly installments beginning on April 3, 2025.

Remarks:

Exhibit 24.1 - Power of Attorney